The service will be incorporated into the Washington-based healthcare system's EHR system in order to advance its precision medicine efforts.
The firm is counting on its experience integrating data from the oil and gas industry to change the way pharmaceutical data scientists work.
Santen Inc., the US subsidiary of Japanese firm Santen Pharmaceuticals, will have exclusive rights to drug candidates discovered by twoXARs algorithms.
Two research groups reported on statistical methods for uncovering methylated cytosine and/or adenine bases using electrical current cues from Oxford Nanopore sequencers.
Researchers used the approach, which analyzes somatic copy number alterations, to identify a targetable pathway, which they then blocked effectively using currently available drugs.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.